61. Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probesStane Pajk, Damijan Knez, Urban Košak, Maja Zorović, Xavier Brazzolotto, Nicolas Coquelle, Florian Nachon, Jacques-Philippe Colletier, Marko Živin, Jure Stojan, Stanislav Gobec, 2020, izvirni znanstveni članek Ključne besede: butyrylcholinesterase, inhibitor, probe, fluorescence Celotno besedilo (datoteka, 1,60 MB) Gradivo ima več datotek! Več... |
62. Fragment-sized and bidentate (immuno)proteasome inhibitors derived from cysteine and threonine targeting warheadsLevente Kollár, Martina Gobec, Matic Proj, Lara Smrdel, Damijan Knez, Stanislav Gobec, Izidor Sosič, György Keserü M., 2021, izvirni znanstveni članek Ključne besede: immunoproteasome, benzoxazole-2-carbonitriles, bidentate covalent inhibitors, fragments, non-covalent recognition Celotno besedilo (datoteka, 1,17 MB) Gradivo ima več datotek! Več... |
63. Treatment of canine cognitive dysfunction with novel butyrylcholinesterase inhibitorMaja Zakošek, Sonja Prpar Mihevc, Malan Štrbenc, Urban Košak, Ilija German Ilić, Jurij Trontelj, Simon Žakelj, Stanislav Gobec, Darja Pavlin, Gregor Majdič, 2021, izvirni znanstveni članek Ključne besede: Alzheimer’s disease, butyrylcholinesterase, butyrylcholinesterase inhibitor, canine cognitive dysfunction, canine dementia scale, dogs Celotno besedilo (datoteka, 1,34 MB) Gradivo ima več datotek! Več... |
|
|
|
67. Synthesis, molecular modelling and biological evaluation of novel heterodimeric, multiple ligands targeting cholinesterases and amyloid betaMichalina Hebda, Marek Bajda, Anna Więckowska, Natalia Szałaj, Anna Pasieka, Dawid Panek, Justyna Godyń, Tomasz Wichur, Damijan Knez, Stanislav Gobec, Barbara Malawska, 2016, izvirni znanstveni članek Ključne besede: cholinesterase inhibitors, molecular modelling, β-amyloid aggregation inhibitors, Alzheimer’s disease, multi-target-directed ligands (MTDL), PAMPA-BBB assay Celotno besedilo (datoteka, 3,87 MB) Gradivo ima več datotek! Več... |
68. Synthesis and biological evaluation of benzochromenopyrimidinones as cholinesterase inhibitors and potent antioxidant, non-hepatotoxic agents for Alzheimer's diseaseYoussef Dgachi, Oscar M. Bautista-Aguilera, Mohamed Benchekroun, Hélène Martin, Alexandre Bonet, Damijan Knez, Justyna Godyń, Barbara Malawska, Stanislav Gobec, Mourad Chioua, Jana Janockova, Ondrej Soukup, Fakher Chabchoub, José Marco-Contelles, Lhassane Ismaili, 2016, izvirni znanstveni članek Ključne besede: Alzheimer's disease, quinazolinones, multicomponent reactions, multitarget-directed ligands, antioxidants, cholinesterase inhibitors, hepatotoxicity Celotno besedilo (datoteka, 1,47 MB) Gradivo ima več datotek! Več... |
69. Discovery of immunoproteasome inhibitors using large-scale covalent virtual screeningAndrea Scarpino, Dávid Bajusz, Matic Proj, Martina Gobec, Izidor Sosič, Stanislav Gobec, György G. Ferenczy, György Keserü M., 2019, izvirni znanstveni članek Ključne besede: immunoproteasome, covalent inhibitor, virtual screening, β5i selective inhibitor Celotno besedilo (datoteka, 3,77 MB) Gradivo ima več datotek! Več... |
70. 4-phenethyl-1-propargylpiperidine-derived dual inhibitors of butyrylcholinesterase and monoamine oxidase BTjaša Mazej, Damijan Knez, Anže Meden, Stanislav Gobec, Matej Sova, 2021, izvirni znanstveni članek Ključne besede: Alzheimer's disease, butyrylcholinesterase, monoamine oxidase B, inhibitors, multi-target-directed ligands, multifunctional ligands Celotno besedilo (datoteka, 3,88 MB) Gradivo ima več datotek! Več... |